Calamos Advisors »

Zura Bio shares owned by Calamos Advisors

Quarter-by-quarter ownership of Zura Bio (ZURA) shares owned by Calamos Advisors from 13F filings

Historical chart of Calamos Advisors investment in Zura Bio

Tip: Access up to 7 years of quarterly data

All positions including Zura Bio held by Calamos Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Zura Bio by Calamos Advisors

Quarter filed Position value Share count Share price at filing
2024-03-31 $54k 200k 0.27

More positions owned by Calamos Advisors

Microsoft Corporation (MSFT)
NVIDIA Corporation (NVDA)
Apple (AAPL)
Amazon (AMZN)
Alphabet Cap Stk Cl A (GOOGL)
Meta Platforms Cl A (META)
Palo Alto Networks Note 0.375% 6/0 (Principal)
Eli Lilly & Co. (LLY)
Pioneer Nat Res Note 0.250% 5/1 (Principal)
Visa Com Cl A (V)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Alphabet Cap Stk Cl C (GOOG)
Broadcom (AVGO)
Invesco Qqq Tr Unit Ser 1 Put Option (QQQ)
UnitedHealth (UNH)

View all positions for Calamos Advisors

Top funds holding Zura Bio

Suvretta Capital Management
Dr. Jeffrey R. Jay, M.D.
Armistice Capital
BlackRock
Citadel Advisors
Vanguard Group
Geode Capital Management
Calamos Advisors
Charles Schwab Investment Management
Northern Trust
Raymond James & Associates
Jane Street
Bank of New York Mellon
Hudson Bay Capital Management
Forefront Analytics

View all funds holding Zura Bio